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Scientific reports suggest that women at risk for familial breast cancer may benefit from prophylactic mastectomy. However, few data
are available about how women decide upon this clinical option, and in particular, what role an objective risk assessment plays in this.
The purpose of the present study is to assess whether this objective risk information provided in genetic counselling affects the
intention for prophylactic mastectomy. Additionally, the (mediating) effects of breast cancer worry and perceived risk are investigated.
A total of 241 women completed a questionnaire before and after receiving information about their familial lifetime breast cancer risk
in a genetic counselling session. Path analysis showed that the objective risk information had a corrective effect on perceived risk
(b¼0.38; P¼0.0001), whereas the amount of breast cancer worry was not influenced by the counselling session. The objective risk
information did not directly affect the intention for prophylactic mastectomy. The intention was influenced by perceived risk after
counselling (b¼0.23; P¼0.002), and by the precounselling levels of perceived risk (b¼0.27; P¼0.00025) and breast cancer worry
(b¼0.32; P¼0.0001), that is, higher levels of perceived risk and breast cancer worry imply a stronger intention for prophylactic
mastectomy. A personal history of breast cancer did not directly influence the intention for prophylactic mastectomy, but affected
women who had undergone a mastectomy as surgical treatment were more positively inclined to have a prophylactic mastectomy
than women who had had breast-conserving therapy. The impact of objective risk information on the intention for prophylactic
mastectomy is limited and is mediated by perceived risk. Important determinants of the intention for prophylactic mastectomy were
precounselling levels of breast cancer worry and perceived risk, suggesting that genetic counselling is only one event in the entire
process of decision making. Therefore, interventions aimed at improving decision making on prophylactic mastectomy should
explicitly address precounselling factors, such as personal beliefs and the psychological impact of the family medical history.
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It is estimated that 5–10% of breast cancer cases are linked to a
breast cancer gene mutation (Evans et al, 1994). Hereditary breast
cancer might be suspected if the family history shows multiple
cases of early-onset breast cancer, cases of male breast cancer, or
cases of bilateral breast cancer, or if cases of breast and ovarian
cancer occur within the same individual or family. For individuals
from such families, genetic counselling is available at a family
cancer clinic. Based on the family illness history, objective risk
information can be provided so that clients can realistically
appraise their own risk. Women with a relatively low risk may be
reassured, while those with a higher risk can make informed
decisions, such as deciding whether or not to undergo a
prophylactic mastectomy.
The clinical option of prophylactic mastectomy remains
controversial (Stefanek et al, 2001), although evidence for a strong
protective effect of prophylactic mastectomy for women with a
familial history of breast cancer has been presented (Hartmann
et al, 1999), and, more specifically, for women with a BRCA1/2
mutation (Hartmann et al, 2001; Meijers-Heijboer et al, 2001). For
instance, Meijers-Heijboer et al (2001) report that of 139 women
with a BRCA1/2 mutation, 55% choose to undergo prophylactic
mastectomy of whom none developed breast cancer, whereas 45%
opted for an intensive-screening programme of whom 12%
developed breast cancer within 2.9 years of follow-up. In addition,
prophylactic mastectomy seems to have positive psychosocial
consequences (Hatcher et al, 2000): high levels of psychological
morbidity and anxiety before surgery decreased significantly over
time after surgery, whereas in women who declined prophylactic
mastectomy, a high anxiety level persisted. This suggests that
women may indeed benefit from prophylactic mastectomy,
although women who have to deal with surgical complications
might warrant psychological help (Hopwood et al, 2000).
Only a few studies have reported on the decision-making
process on prophylactic mastectomy of high-risk women (Stefanek
et al, 2001). In a prospective study, Stefanek et al (1995) described
that higher subjective risk estimates, biopsy history, and a higher
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llevel of breast cancer-related worry might be associated with the
decision to have a prophylactic mastectomy. In a cross-sectional
study, Meiser et al (2000) investigated a large sample of unaffected
women, who were awaiting their initial appointment for genetic
counselling. The intention to choose for prophylactic mastectomy
was predicted by a very high level of breast cancer anxiety and an
overestimation of the risk to develop breast cancer, whereas the
objective risk of developing breast cancer did not predict intention
for prophylactic mastectomy. However, hardly any data are
available about the possible role of the objective risk assessment
in the decision-making process.
The current study presents prospective data on whether the
intention to undergo prophylactic mastectomy is influenced by (1)
the objective level of risk as provided in genetic counselling; (2)
pre- and postcounselling levels of breast cancer worry and
perceived risk; and (3) a personal history of breast cancer. Three
features distinguish the present study from other studies of
prophylactic surgery decision making, that is, (a) the comparison
of a pre- and postcounselling survey; (b) the inclusion of women
with a history of breast cancer; and (c) the broad study population
inclusive of both low- and high-risk women.
METHODS AND MATERIALS
Participants and procedure
Data were collected within the framework of a larger study on risk
perception and decision making by women at risk for hereditary
breast cancer. For the integrative study, ethical approval was
obtained from the hospital’s research ethics committee. Partici-
pants were at least 18 years of age with a family and/or a personal
history of breast cancer who applied for genetic counselling at the
Department of Clinical Genetics of the Leiden University Medical
Center. Referrals for genetic counselling on breast cancer were
based on current national guidelines (De Bock et al, 1999). In the
first (and sometimes only) consult, a clinical geneticist interviewed
the women applying a standard counselling protocol, and recorded
their family medical history. Information was provided about the
hereditary transmission of BRCA1 and BRCA2, and about
surveillance, if applicable. Genetic testing was offered if there
was a probability of mutation detection of about 10% or more. If
sufficient medical information was available, a familial lifetime risk
of developing breast cancer was estimated (Claus et al, 1994). Four
risk categories were distinguished: (1) general population risk, that
is, around 10%; (2) 10–15%; (3) 15–30%; and (4) 30% or more.
The standard protocol of the first consultation did not cover any
discussion about pros and cons of prophylactic mastectomy. If
supplementary medical information had to be collected or if
genetic testing was applied, further appointments were scheduled
(53% of the women). In general, for women with a relatively low
risk and who were not eligible for genetic testing, no further
appointments were made (47% of the women). (Further appoint-
ments fell outside the scope of the data reported here, as all
measures were conducted before and after the first consultation.)
All new referrals for breast cancer counselling from November
1998 until July 2001 were informed about this study by letter 2
weeks before their first appointment. Eligible women who returned
the written consent form that accompanied the informative letter
received the first questionnaire by mail prior to their first
appointment. Immediately after this counselling session, a second
questionnaire was sent out, irrespective whether follow-up
appointments were scheduled. Reminder letters were sent, if
appropriate. Women were excluded from the study if they had not
received information about their familial lifetime risk during the
counselling session, had lost both breasts due to previous surgery,
had distant metastases, or if they had an insufficient literacy in the
Dutch language.
MEASURES
Sociodemographic characteristics Information on personal his-
tory of breast cancer (i.e. unaffected or affected women), surgical
procedure to treat breast cancer (i.e. mastectomy or breast-
conserving therapy), age, educational level, marital status, and
number of children was collected.
Breast cancer-related worry In both questionnaires, we assessed
breast cancer-related worry with two items of the breast cancer
worries scale (Lerman et al, 1991). These items were as follows:
‘During the last 2 weeks, how often did you worry about
developing breast cancer yourself (again)?’, and ‘During the last
2 weeks, how often did your worries about breast cancer interfere
with your daily activities?’ on a four-point scale ranging from 1
(almost never) to 4 (almost all the time). The mean of both items
was calculated (scores ranged from 1 to 4), with higher scores
indicating a higher level of breast cancer-related worry. The
reliability of this scale was satisfactory (precounselling: Cronbach’s
a¼0.66; postcounselling: Cronbach’s a¼0.73).
Perceived risk of breast cancer Perceived risk was assessed in
both questionnaires with a comprehensive scale that included
various aspects of perceived risk: (1) relative perceived lifetime
risk of getting breast cancer was measured with the item
‘Compared to the average Dutch woman, my risk of developing
breast cancer (again) is 1 ‘very much lower’, through 4 ‘equal to’,
to 7 ‘very much higher’, (2) numerical perceived lifetime risk of
getting breast cancer was measured with the item ‘My risk of
developing breast cancer (again) is y out of 100’, and (3) verbal
risk with the item ‘Independent of my actual risk, I feel my risk of
developing breast cancer (again) is 1 ‘very low’ to 7 ‘very high’.
Perceived risk was measured in both the questionnaires. As the
range of items varied, standardised scores of the separate items
were used. The precounselling measures of perceived risk were
each z-transformed. The postcounselling measures were similarly
standardised also using the mean and standard deviation of the
corresponding precounselling items. The mean of the three
standardised items constituted the perceived risk scale. The scale
had an adequate reliability (precounselling: Cronbach’s a¼0.78;
postcounselling: Cronbach’s a¼0.73). Larger values on the scale
indicated a higher perceived risk.
Intention for prophylactic mastectomy In the second question-
naire, the intention for prophylactic mastectomy was measured
with the item ‘Do you expect to decide for preventive surgery of
your breasts’ on a seven-point scale ranging from 1 ‘certainly not’
to 7 ‘yes, certainly’. This item was considered as potentially
confronting to women. Therefore, the intention for prophylactic
mastectomy was measured only after the counselling session.
Statistical methods
The SPSS 10.0 statistical package was used to analyse the data. Path
analysis was applied to examine the research questions with
several multiple regression analyses (Cohen and Cohen, 1983).I n
the first phase, we checked whether the objective risk provided in
the counselling was related to either having had breast cancer (no
or yes), or to the precounselling measures of perceived risk and
breast cancer worry.
In the second phase, we applied two multiple regression analyses
to assess whether there was a change in perceived risk, respectively
in worry, and, if so, which factors predicted the change. In order to
do so, the change scores between the pre- and postcounselling
scales of (a) perceived risk and (b) worry were calculated by
subtracting the precounselling value from the postcounselling
value. Thus, a positive value indicated increased worry or
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lperceived risk, and a negative value implied decreased worry or
perceived risk after the counselling session. These two change
scores served as outcome variables. Four predictor variables were
used in each analysis: (a) having had a personal history of breast
cancer, (b) the objective risk information, and the precounselling
measures of (c) perceived risk, and (d) worry. The precounselling
measures of perceived risk and worry were included, because the
possible range of change is determined by the precounselling
values. However, the interpretation of predictive effects of the
precounselling measures on the change measures is hampered by
the fact that the precounselling measure is a constituent part of the
change score. Therefore, we will not describe the relations between
the precounselling measures and the corresponding change scores
in the path analysis. (However, Pearson’s correlations are
presented in Table 3.)
In the third phase, the intention for prophylactic mastectomy
was predicted from all previous variables. In this phase, we also
wanted to examine whether the overall model to predict intention
for prophylactic mastectomy would differ between women from
the highest risk category (i.e. 430%) and women in the lower risk
category (i.e. p30%). The choice for this dichotomy was based on
the fact that only women in the highest risk category will be
eligible for genetic testing as the chance to harbour a BRCA
mutation must be sufficiently high. Two-way interaction variables
with risk status (multiplication of centred scores) were included in
the analysis (e.g. interaction between worry, precounselling and
the change score, and risk status; perceived risk, precounselling
and the change score, and risk status; and breast cancer history
and risk status).
To check whether the observed relations in phases 1–3 would
differ between affected and unaffected women, two-way interaction
variables with breast cancer history were included in the analyses
in a similar way as described above for risk status interactions (e.g.
interaction between worry, precounselling and the change score,
and breast cancer history; perceived risk, precounselling and the
change score, and breast cancer history; and objective risk and
breast cancer history). In addition, for affected women we
examined whether the surgical procedure to treat their breast
cancer served as an additional predictor in the phases 1–3
regression analyses.
For each multiple linear regression analysis, we report the extent
of variance in the criterion explained by the regression (R
2), the
significance of the explained variance (F-test), and which
predictors significantly contributed to this explained variance (b-
weights). A P-value o0.05 was considered to indicate statistical
significance.
RESULTS
Study population
Of the 454 women who met the inclusion criteria, 350 consented to
participate in the study (response rate 77.1%). Of these 350, 44
women returned their informed consent just at the first counsel-
ling session, instead of mailing it beforehand. Therefore, they
could not complete the precounselling questionnaire. Another
three were excluded from the analysis because they did not return
the precounselling questionnaire in time, whereas 13 women did
not complete all items of the precounselling questionnaire. Finally,
30 women did not return the postcounselling questionnaire, and 19
women did not complete all items of the postcounselling
questionnaire. This left 241 women for our analyses.
T-tests and chi square tests showed that the women who did not
complete the pre- or the postcounselling questionnaire did not
differ from women who did complete all items of both
questionnaires on the measures relevant for this study (objective
risk, perceived risk, breast cancer worry, intention mastectomy,
personal history of breast cancer, known mutation running in the
family, age, marital status, educational level). On only one variable
these groups differed. Women who did not complete the pre- or
postcounselling questionnaire reported having children more
frequently (P¼0.025) than women who did complete all items of
both questionnaires.
Sociodemographic characteristics Table 1 summarises the socio-
demographic and medical variables of the study population. The
mean age of the group was 41.4 years (range 19–71 years; s.d. 11.0
years). The majority of the women was married or cohabitating
and had one or more children. Almost half of the women was
educated to high school or university level. A small minority of the
women had at least one close family member in whom a BRCA1 or
BRCA2 mutation had been detected.
Description of the outcome and predictor variables Of the 241
women, 168 were healthy and 73 had been treated for breast cancer
(36 mastectomy, 36 breast-conserving therapy, one unknown). In
the counselling session, more than half of the women (n¼136) was
classified into the highest risk category (i.e. a risk of more than
30% to develop breast cancer; see Table 1), and were consequently
eligible for genetic testing. The objective risk was not related to any
of the sociodemographic variables. Not surprisingly, women with a
known BRCA1 or BRCA2 mutation in the family had a significantly
higher objective risk, than women without a known BRCA1 or
BRCA2 mutation running in the family (P¼0.0001).
Table 2 depicts the mean values of the individual items used to
measure breast cancer worry and perceived risk. The majority of
the women had no excessive breast cancer-related worry either
before or after counselling (precounselling M¼1.70; postcounsel-
ling M¼1.72). Most women stated that they almost never or only
sometimes worried about developing breast cancer (precounselling
73.8%; postcounselling 72.2%). Similarly, almost all women
reported that worries about breast cancer almost never or only
Table 1 Sociodemographic and medical variables of the study popula-
tion
n%
Sociodemographic
Age (years)
o30 39 16.2
30–39 64 26.5
40–49 79 32.8
50+ 59 24.5
Marital status
Married or cohabitating 194 80.5
Not married or cohabitating 47 19.5
Children
Yes 162 67.2
No 79 32.8
Educational level
High school or university 95 39.4
Less than high school 146 60.6
Medical
Breast cancer history
Yes 73 30.3
No 168 69.7
Objective risk (%)
10 (population risk) 10 4.1
10–15 22 9.1
15–30 73 30.3
430 136 56.5
BRCA detected in family
Yes 25 10.4
No 216 89.6
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lsometimes interfered with their daily activities (precounselling
94.2%; postcounselling 94.2%).
The perceived risk prior to and after the counselling session was
high. The vast majority of the women (precounselling 89.2%;
postcounselling 86.7%) thought their risk to be higher than the
average Dutch woman’s risk. In addition, approximately half of the
women (precounselling 60.2%; postcounselling 55.2%) stated that,
independent of their actual risk, they felt they had a high risk of
developing breast cancer (again). Finally, most of the women
perceived their numerical risk to develop breast cancer (again) to
be 30% or more (precounselling 86.3%; postcounselling 74.7%).
Figure 1 displays the data on the intention to choose for
prophylactic mastectomy. Overall, the majority of the women
certainly or probably expected to decide against prophylactic
mastectomy (54.4%), whereas 19.9% certainly or probably
expected to decide for prophylactic mastectomy. A quarter of the
women was undecided (25.7%).
Description of the path analysis
Path analysis was applied to examine our research questions.
Below, each multiple regression analysis is described separately.
Table 3 shows the zero-order Pearson’s correlations between the
predictor and outcome variables; Figure 2 depicts the combined
results.
Phase 1: was the objective risk information related to precounselling
variables? Neither the precounselling measure of breast cancer-
related worry (P¼0.53), nor having had a primary breast tumour
(P¼0.51) was associated with the objective risk information.
However, the perceived risk women reported before the consult
was positively related to their actual risk (b¼0.15; P¼0.037). The
model was significant in explaining objective risk (F(3,237)¼2.71,
P¼0.046, R
2¼0.033).
Phase 2a: Did perceived risk change after counselling and which
factors predicted such a change? Overall, perceived risk decreased
after the counselling session (constant¼ 1.33; P¼0.0001). As
expected, the objective risk information influenced this change in
perceived risk (b¼0.38; P¼0.0001). Women with a relatively low
objective risk reported a lower perceived risk after counselling,
whereas women with a relatively high objective risk remained at a
high level of perceived risk after counselling. This means that after
counselling women shifted towards a more accurate perceived risk.
To illustrate this point, we looked at the numerical risk estimates
that women provided. Before the counselling, 83% of the low-risk
women overestimated their risk and after counselling 56%
overestimated their risk. In contrast, of the high-risk women
89% correctly identified their high-risk status before and after
counselling. The change in perceived risk was also predicted by
having had breast cancer (b¼0.14; P¼0.015). Unaffected women
showed a stronger decrease in perceived risk after counselling than
women with a history of breast cancer. The regression model was
significant in explaining the change in perceived risk
(F(4,236)¼29.80, P¼0.0001, R
2¼0.34).
Phase 2b: Did the amount of breast cancer worry change after
counselling and which factors predicted such a change? Overall,
breast cancer-related worry slightly increased after the counselling
session (constant¼0.56; P¼0.001). The objective risk informa-
tion, as provided in the counselling, did not influence the change
in breast cancer worry after counselling (P¼0.61). Having had a
primary breast tumour (b¼0.18; P¼0.003) predicted the change
in worry. Women who had had a primary breast tumour reported a
higher level of breast cancer worry after counselling, whereas
unaffected women showed no change in the amount of worry after
counselling. The regression model was significant in explaining the
change in breast cancer worry (F(4,236)¼14.35, P¼0.0001,
R
2¼0.20).
Phase 3: Which variables predicted the intention for prophylactic
mastectomy? Precounselling levels of breast cancer worry
(b¼0.32; P¼0.0001) and perceived risk (b¼0.27; P¼0.00025)
both independently predicted the intention for prophylactic
mastectomy. Women who had higher prior levels of breast cancer
worry and/or a higher prior perceived risk reported a stronger
intention to choose for prophylactic mastectomy. Intention for
prophylactic mastectomy was also predicted by the change in
perceived risk after the counselling session (b¼0.23; P¼0.002);
women who shifted towards a lower perceived risk, reported a
weaker intention for prophylactic mastectomy. As phase 2a
showed, this change in perceived risk was influenced by the
objective risk information. Although the objective risk did not
Table 2 Worry and risk perception precounselling and postcounselling
Precounselling Postcounselling
Breast cancer-related worry (scale) 1.70 (0.65) 1.72 (0.64)
How often did you worry about developing breast cancer yourself (again)? (1–4) 2.01 (0.82) 2.07 (0.83)
How often did your worries about breast cancer interfere with your daily activities? (1–4) 1.32 (0.62) 1.32 (0.61)
Perceived risk (scale) 0.00 (0.83)  0.24 (0.81)
Compared to the average Dutch woman, my risk of developing breast cancer (again) is (1–7) 5.83 (1.21) 5.68 (1.16)
My risk of developing breast cancer (again) is y out of 100 54.93 (21.31) 43.86 (21.03)
Independent of my actual risk, I feel my risk of developing breast cancer (again) is (1–7) 4.72 (1.15) 4.63 (1.23)
Mean score and standard deviation are given in brackets.
26
12
16
26
11
2
7
0 5 10 15 20 25 30
Certainly not
Not
Probably not
Maybe yes,
maybe not
Probably yes
Yes
Certainly yes
Figure 1 Intention to undergo prophylactic mastectomy (percentages).
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lhave a direct effect on the intention (P¼0.78), the objective risk
information had an indirect effect by adjusting perceived risk,
which in turn affected the intention.
The change in worry after the counselling session did not add to
the prediction of the intention for prophylactic mastectomy
(P¼0.082). Finally, having had a primary breast tumour had no
direct influence on the intention for prophylactic mastectomy
(P¼0.67). However, as shown in phase 2a, having had breast
cancer influenced the change in perceived risk and, consequently,
had an indirect effect on the intention for prophylactic mastect-
omy. The full regression model was significant in explaining the
intention for prophylactic mastectomy (F(6,234)¼10.99,
P¼0.0001, R
2¼0.22).
Interaction effects of risk status on intention for prophylactic
mastectomy The inclusion of the interaction variables with risk
status did not affect the overall model as depicted in Figure 2, as all
the same main effects remained significant at a similar level. In
addition, none of the interaction variables reached significance
(Ps40.102), indicating that the same model applied to low- as well
as to high-risk status women.
Interaction effects of breast cancer history and breast cancer
surgery No effects are observed for the interaction variables with
breast cancer history in the phases 1–3 regression analyses,
indicating that the relations depicted in Figure 2 similarly apply to
healthy and affected women.
For affected women, the kind of surgical procedure to treat their
breast cancer did not predict the objective risk estimate, nor the
change in perceived risk or breast cancer worry. However, the
intention for prophylactic mastectomy was predicted by the kind
of surgical procedure (b¼0.22; P¼0.040): women who had had a
mastectomy showed a stronger intention to have a prophylactic
mastectomy of the contralateral breast than women who had had
breast-conserving surgery. Thus, for affected women the kind of
surgical procedure served as an additional predictor, next to the
precounselling levels of perceived risk and worry, and the change
in perceived risk after counselling.
DISCUSSION
The impact of the objective risk information provided in genetic
counselling on the intention to opt for prophylactic mastectomy is
relevant, but limited. First, the objective risk information had an
indirect effect on the intention through the perceived risk of
developing breast cancer: counselling a lower objective risk
decreased the perceived risk after counselling, which related to a
weaker intention to opt for prophylactic mastectomy. Second, both
stronger breast cancer worry and a higher perceived risk about
developing breast cancer before counselling promoted the inten-
tion for mastectomy.
The finding that perceived risk has a stronger impact on
preventive intentions than objective risk is consistent with studies
assessing those relations before the counselling (e.g. Stefanek et al,
1995; Meiser et al, 2000). The present study shows that the impact
of the objective risk information on the intention for prophylactic
mastectomy is mediated through the change in perceived risk after
counselling. These results stress the importance of assessing
women’s perception of the risk in order to understand their
decisions and behaviour regarding prophylactic mastectomy (see
also Hatcher et al, 2000).
The present study clearly shows that the objective risk
information had a corrective effect on perceived risk, but it was
a moderate impact in terms of explained variance: 14% of the
variance in the change of perceived risk was due to the objective
risk information. This points at other factors in- or outside the
counselling session that possibly affect the change of perceived
risk. All in all, our results are in line with previous studies showing
that genetic counselling generally improves perceived risk, but
often women tend to report an inaccurate risk of developing breast
cancer even at 1-year follow-up (Watson et al, 1999; Meiser et al,
2001; Meiser and Halliday, 2002).
High levels of worry and perceived risk before women approach
the geneticist strongly related to the intention for prophylactic
mastectomy. This supports the notion that the counselling is not
the onset of deliberations regarding prophylactic mastectomy, but
an element in an earlier started and ongoing process. The results
even suggest that the objective risk information provided in the
counselling may be a relatively small event in this process of
decision making. This fits recent acknowledgements that pre-
counselling factors like past cancer stressors are important
determinants for subsequent distress and behaviour (Zakowski
et al, 1998; Baider et al, 1999; Erblich et al, 2000; Rees et al, 2001).
The personal experience of the counsellee, including concomitant
fears and emotional beliefs, is an essential element of the
counselling interaction. Only if this experience and its emotions
are discussed openly and understood, will it be clear to both
counsellor and counsellee what the full scale of the problem is, and
to what extent objective risk assessment may or may not solve this
problem.
Table 3 Pearson correlation between the predictor and the outcome variables
Variable 1 2 3 4 5 6
1 Breast cancer (no/yes)
2 Perceived risk (before)  0.162*
3 Worry (before) 0.104 0.389***
4 Objective risk  0.063 0.174** 0.098
5 Perceived risk (change) 0.187**  0.429***  0.132* 0.286***
6 Worry (change) 0.122  0.151*  0.407***  0.017 0.240***
7 Intention mastectomy 0.071 0.284*** 0.356*** 0.158* 0.103 0.000
* Po0.05, ** Po0.01, *** Po0.001.
Worry 
Breast cancer
 
Perceived risk 
Risk assessment
Change in 
perceived risk 
Intention 
mastectomy 
Change in 
worry 
0.18**
0.38*** 
0.23**
0.32*** 
0.27*** 
0.14*
Precounselling Postcounselling
0.15*
Figure 2 Full regression model with Beta’s (*Po0.05, **Po0.01,
*** Po0.001).
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lAbout a third of the women who applied for genetic counselling
in the present study had had a primary breast tumour. Breast
cancer history had no direct impact on the intention for
prophylactic mastectomy: affected and unaffected women had
the same, somewhat negative, intentions. Moreover, the interaction
analyses showed that the same relations applied for both healthy
and affected women. This corroborates the findings of Julian-
Reynier et al (2001) that affected women did not differ from
healthy women regarding their attitude towards the acceptability
of prophylactic mastectomy after multivariate adjustment. How-
ever, for affected women the kind of surgical procedure to treat
their breast cancer had a direct impact: women who had
undergone a mastectomy were more positively inclined towards
a prophylactic mastectomy of the contralateral breast than women
who had had breast-conserving therapy. Probably, uncertainty
reduction and cosmetic reasons do not only apply to the decision
how to treat breast cancer, but also to preventive management.
Nonetheless, in the present study breast cancer history did have
an indirect effect through risk perception on the intention. Healthy
women showed a stronger decrease in perceived risk than affected
women, and a decreased risk perception was related to a weaker
intention. Affected women were also more worried after counsel-
ling, although this did not influence the intention. In contrast, a
recent study (Bish et al, 2002) did not find differences on perceived
risk nor worry between affected and unaffected women. An
explanation for the present findings is that the recurrence risk of
breast cancer constitutes a possible topic in the counselling
session. This might induce distress and a sense of vulnerability in
affected women who may have felt relatively safe after having had
breast cancer.
A few limitations of this study should be noted. First, we want to
mention that a relatively large proportion of respondents, who
provided written informed consent for the study, did not complete
both questionnaires, mainly due to logistic problems. However,
women who did not complete the questionnaires were comparable
to women who did. As a consequence, we think the results are
generalisable to the population of women that seek genetic
counselling.
Secondly, one could view the use of intention instead of actual
behaviour as a restriction. The actual use of prophylactic
mastectomy will probably fall below levels of intended use (e.g.
Lerman et al, 2000). However, the goal of the present study was to
prospectively assess the impact of objective risk information on
thoughts about prophylactic mastectomy for all women applying
for genetic counselling for breast cancer; thus, not restricting the
sample to either unaffected women or high-risk women who are
eligible for genetic testing. The present sample probably covers the
variety of women that seek genetic counselling now that hereditary
breast cancer and genetic testing have become a topic that receives
a lot of media attention. Our data suggest that for both low- and
high-risk women their intention is not clearly guided by their
objective risk, although only the latter women are eligible for DNA
testing, and possibly prophylactic mastectomy. This points at the
possibility that women at a lower risk for breast cancer may have
similar desires concerning their risk management as women with a
very high risk (see Bottorff et al, 2000). The effect of DNA-testing
results on high-risk women’s actual decisions regarding prophy-
lactic mastectomy and low-risk women’s risk management beliefs
and behaviours will be explored in other papers.
Third, in our study we confined genetic counselling to providing
information about the familial lifetime risk to develop breast
cancer. This does not acknowledge the interactive features and the
many other topics and goals that characterise the counselling
process, which may also affect subsequent perceptions and
behaviours (see Lobb et al, 2002). The effect of breast cancer
history on worry after counselling illustrates this point: apparently,
an element other than the objective risk information provided in
the counselling increased the worry in affected women relative to
unaffected women.
The main advantages of the present study concern the diversity
of the participants, and the prospective design. Most importantly,
it shows (a) the relevant, but limited impact of objective risk
information on postcounselling deliberations, and (b) the major
impact of precounselling factors on these deliberations. Health-
care professionals should be aware of the specific limitations of
counselling, and of the potential impact of women’s personal
experiences and beliefs concerning breast cancer. These precoun-
selling factors should be explicitly addressed in the genetic
counselling protocol, and should be a guiding element in the
process of providing information.
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